Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00MQS
|
|||
| Former ID |
DCL000919
|
|||
| Drug Name |
PD-165167
|
|||
| Synonyms |
CHEMBL332154; SCHEMBL8169927; BDBM50080797; 7-[[(2-Anilinoethyl)amino]methyl]coumarin; L017812
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Preclinical | [1] | |
| Company |
Pfizer
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H18N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)NCCNCC2=CC3=C(C=C2)C=CC(=O)O3
|
|||
| InChI |
1S/C18H18N2O2/c21-18-9-8-15-7-6-14(12-17(15)22-18)13-19-10-11-20-16-4-2-1-3-5-16/h1-9,12,19-20H,10-11,13H2
|
|||
| InChIKey |
RNNKCHJUBXFBQB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.